Nucleic Acid Based Gene Therapy Market Trends, Top Companies, Share, Growth And Forecast 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Nucleic Acid Based Gene Therapy Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $1.2 billion In 2028 At A CAGR Of 10.1% :

The nucleic acid based gene therapy market size has grown strongly in recent years. It will grow from $0.75 billion in 2023 to $0.82 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to growing understanding of human genetics, growing demand for personalized medicine, expanding pipeline of gene therapy products, growing government support for gene therapy, genetic disorders, cancer therapy.

The nucleic acid based gene therapy market size is expected to see rapid growth in the next few years. It will grow to $1.2 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to expanding indications, increased funding, patient advocacy and awareness, growing investment in gene therapy research and development, expanding scope of gene therapy applications, rare diseases. Major trends in the forecast period include ex vivo gene editing, advances in in vivo gene editing, combination therapies, targeted delivery systems, gene editing for rare diseases, non-viral vectors.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=2820&type=smp

Nucleic Acid Based Gene Therapy Market Major Segments
The nucleic acid based gene therapy market covered in this report is segmented -

1) By Technology: Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies
2) By Application: Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases
3) By End User: Hospitals And Clinics, Academic And Research Institutes

Key Driver - Government And Industry Backing Fueling The Surge In Nucleic Acid-Based Gene Therapy Demand

Rising financial support by the government and the companies is projected to drive the demand for nucleic acid-based gene therapy. Nucleic acid therapeutics are analogs of naturally occurring acids or proteins responsible for genetic expression. The traditional therapies do not have any cure for the treatment of diseases such as cystic fibrosis, hemophilia, sickle cell anemia, thalassemia, and diabetes. Genetic profiling and molecular target identification form the backbone of these classes of drugs. Nucleic acid medication has greater potential for the treatment of these diseases, as they target the genetic basis of diseases and have a permanent cure. Rising financial support by the government and the companies dealing in the market for gene therapy is expected to contribute to increasing the demand for nucleic acid-based gene therapy market. For instance, in August 2022, National Institute of Health (NIH) announced investment of $34 million annually for upcoming 5 years to develop HIV treatment research. The government support for gene therapies will contribute to the growth of the nucleic acid based gene therapy market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=2820&type=smp

Prominent Trend - Innovative Drug Development Pioneering Advancements In The Nucleic Acid Drugs Market

Major companies operating in the nucleic acid drugs market are developing innovative drugs such as Casimersen to drive revenues in the market. Casimersen is an ASO indicated for the treatment of DMD in patients with a confirmed mutation amenable to exon 45 skipping. For instance, in February 2021, Sarepta Therapeutics Inc., a US-based biotechnology company launched Casimersen (Amondys 45) approved by the Food and Drug Administration, a US-based government agency. This indication is based on a statistically significant increase in dystrophin production in skeletal muscle observed in patients treated with AMONDYS 45, and predicted a clinical benefit for those patients who are exon 45 amenable.

Nucleic Acid Based Gene Therapy Market Players
Major companies operating in the nucleic acid based gene therapy market include Celsion Corporation, Wave Life Sciences, Imugene Ltd., Caperna LLC, Phylogica Limited, Protagonist Therapeutics Inc., Benitec Biopharma Ltd., EGEN, BioMedica, Transgene SA, Copernicus Therapeutics Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Alnylam Pharmaceuticals Inc., Amgen Inc., Beam Therapeutics Inc., BioNTech SE, Bluebird Bio Inc., CRISPR Therapeutics AG, Editas Medicine Inc., Genevant Sciences Inc., Homology Medicines Inc., Intellia Therapeutics Inc., Ionis Pharmaceuticals Inc., MaxCyte Inc., Moderna Inc., Novartis International AG, Orchard Therapeutics plc, Precision BioSciences Inc., REGENXBIO Inc.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the nucleic acid-based gene therapy market in 2023. Western Europe was the second-largest region in the nucleic acid-based gene therapy market report. The regions covered in the nucleic acid based gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Nucleic Acid Based Gene Therapy Market Report Structure
3. Nucleic Acid Based Gene Therapy Market Trends And Strategies
4. Nucleic Acid Based Gene Therapy Market - Macro Economic Scenario
5. Nucleic Acid Based Gene Therapy Market Size And Growth
…..
27. Nucleic Acid Based Gene Therapy Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.